A prospective longitudinal cohort study describing quality of life in patients undergoing pulmonary metastasectomy for metastatic sarcoma

Not Applicable

Recruiting

• Conditions: To evaluate the health-related quality of life (HRQOL) associated with pulmonary metastasectomy (PM) from metastatic sarcoma; Cancer - Sarcoma (also see 'Bone') - soft tissue

• Registration Number: ACTRN12611000504910
• Lead Sponsor: Australasian Sarcoma Study Group (ASSG)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-05-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

1. Metastatic bone or soft tissue sarcoma
2. Lung-only metastases
3. Planned pulmonary metastasectomy
4. Age greater than or equal to 18 years
5. Signed informed consent

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate the health-related quality of life (HRQOL) associated with pulmonary metastasectomy (PM) (specifically patient-reported dysponea, cough, chest pain, fatigue, physical functioning, role functioning, social functioning, emotional functioning and overall HRQOL).<br>HRQOL will be evaluate via The Patient-Reported Outcomes Measurement Information System (PROMIS) which is an electronic system aimed at improving and standardising measurement of patient-reported outcomes (PROs).[Patients will be recruited over 2 years and will be followed up for 3 years after accrual of the last patient or until death.<br>Patient will be asked to complete HRQOL Assessments prior to their PM surgery, after discharge from hospital, 3-4 weeks after PM surgery, 3-4 months after PM surgery, 8-9 months after PM surgery, 12 months after PM surgery, 2 years after PM surgery and 3 years after PM surgery.]